United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2020_register
executive
2020-07-11
article
Schedules of Controlled Substances: Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I
Part V
Proposed Rules
D09002ee1c102b7bb
D09002ee1c102b883
United States
Department of Justice
originator
org
United States Government Agency or Subagency
United States
Drug Enforcement Administration
originator
org
United States Government Agency or Subagency
The Drug Enforcement Administration (DEA) proposes placing naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (trivial names: NM2201; CBL2201), N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5- fluoropentyl)-1H-indazole-3-carboxamide (trivial name: 5F-AB-PINACA), 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (trivial names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA, SGT-78), methyl 2-(1-(cyclohexylmethyl)-1H- indole-3-carboxamido)-3-methylbutanoate (trivial names: MMB-CHMICA, AMB-CHMICA), and 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H- pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name: 5F-CUMYL-P7AICA), including their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle NM2201, 5F-AB- PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA, and 5F-CUMYL-P7AICA.
85 FR 42290
https://www.govinfo.gov/app/details/FR-2020-07-13/2020-14901
2020-14901
fr13jy20-21
4410-09-P
Docket No. DEA-479
https://www.govinfo.gov/app/details/FR-2020-07-13/2020-14901
https://www.govinfo.gov/content/pkg/FR-2020-07-13/html/2020-14901.htm
https://www.govinfo.gov/content/pkg/FR-2020-07-13/pdf/2020-14901.pdf
Administrative Practice and Procedure
Drug Traffic Control
Reporting and Recordkeeping Requirements
6 p.
42290
42295
85 FR 42290
Code of Federal Regulations
Title 21 Part 1308
21 CFR Part 1308
Schedules of Controlled Substances: Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I; Federal Register Vol. 85, Issue
PRORULE
2020-14901
V
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
2020-08-12
Docket No. DEA-479
4410-09-P
2020-14901
Notice of proposed rulemaking.
The Drug Enforcement Administration (DEA) proposes placing naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (trivial names: NM2201; CBL2201), N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5- fluoropentyl)-1H-indazole-3-carboxamide (trivial name: 5F-AB-PINACA), 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (trivial names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA, SGT-78), methyl 2-(1-(cyclohexylmethyl)-1H- indole-3-carboxamido)-3-methylbutanoate (trivial names: MMB-CHMICA, AMB-CHMICA), and 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H- pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name: 5F-CUMYL-P7AICA), including their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle NM2201, 5F-AB- PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA, and 5F-CUMYL-P7AICA.
Comments must be submitted electronically or postmarked on or before August 12, 2020.
Scott A. Brinks, Regulatory Drafting and Policy Support Section, Diversion Control Division, Drug
Administrative Practice and Procedure
Drug Traffic Control
Reporting and Recordkeeping Requirements
Schedules of Controlled Substances:
Placement of NM2201, 5FABPINACA, 4CNCUMYLBUTINACA, MMBCHMICA and 5FCUMYLP7AICA in Schedule I,
http://www.regulations.gov
Regulations.gov
Federal Register
Vol. 85, no. 134
Office of the Federal Register, National Archives and Records Administration
2020-07-13
continuing
daily
deposited
born digital
402 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2020-07-13
P0b002ee1a765ed77
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr13jy20
https://www.govinfo.gov/app/details/FR-2020-07-13
https://www.govinfo.gov/content/pkg/FR-2020-07-13/pdf/FR-2020-07-13.pdf
https://www.govinfo.gov/content/pkg/FR-2020-07-13/xml/FR-2020-07-13.xml
fdlp
41905
42297
DGPO
2020-07-11
2023-09-26
FR-2020-07-13
machine generated
eng
FR
FR-2020-07-13
85
134